In 2021, the Asia Pacific advanced wound dressing market size was expected to reach a size of billion dollars in the year 2030, which would represent a compound annual growth rate apporx. (CAGR) of 4.3% for the forecast period (2022–2030).
Wounds are being classed as acute and chronic. There are standard and sophisticated wound care and closure solutions for their treatment. Chronic wounds are the wounds that are hard to heal, require extensive time to cure, and are expensive to treat. Advanced wound care and closure solutions are developing as a common method for treating chronic wounds. Many firms in this sector are seeking to increase their product portfolio in order to top this Industry. The major firms are purchasing other companies in this industry as their plan to control this market.
The term "advanced wound care" refers to the provision of medical supplies for the treatment of both acute and chronic wounds, including lesions, burns, and post-operative injuries. The advanced wound care therapies such as film and foam dressings, hydrogels, alginates, and hydrocolloids keep the wound moist and expedite the healing process without interfering with the process. People who suffer from chronic wounds can be assisted by the advanced wound care sector, which can provide these patients with goods that are convenient to get, affordable, and suitable for usage at the patients' own discretion. Chronic wounds are growing more prevalent, as are surgeries, and technology developments are driving the industry ahead. The market is being driven forward by technical breakthroughs.
Treatment of advanced wounds dressing goods are a sort of dressing products that are specifically designed for the treatment of both acute and chronic wounds. Healing a chronic wound might take far longer than an acute one and is associated with higher medical costs. This method of treating wounds is quickly becoming the gold standard for the treatment of chronic wounds. People who live with chronic wounds, which are typically time-consuming and expensive to treat, can now find some relief because to technological advancements in wound care equipment. In this respect, technological advancement has made great development. Because they promote faster healing of chronic wounds, advanced wound care products are rapidly displacing their more conventional equivalents in the medical industry.
Patients who suffer from chronic wounds are the target audience for the advanced wound care industry, which provides treatments that are easy to obtain and affordable. The treatment for advanced wound care includes intervention therapies and products such as collagen products, hydrocolloids, antimicrobial dressings, foam dressings, alginate dressings, gauze composites, film dressings, and hydrogels. Other types of dressings include foam dressings, gauze composites, and film dressings. Patients in North America who are affected with chronic wounds are seeing an improvement in their quality of life as a result of the rapidly advancing and increasingly user-friendly technologies.
Patients who are suffering from wounds are catered to by the APAC Advanced Wound care market, which offers items that are practical and easy to use. Intervention therapies and products are used in advanced wound care treatment. These treatments and products include collagen groducts, foam dressings, hydrocolloids, alginate dressings, gauze composites, and hydrogels. Patients in Asia-Pacific who are affected with chronic wounds should expect an improvement in their quality of life as medical technology continues to develop and become a more practical alternative.
The primary factors that are driving the advanced wound care market in APAC are the expanding elderly population, the rising prevalence of chronic wounds and diabetes, the rising prices of healthcare facilities, and the regulations of the regional governments. Demand in the market is being driven higher by the increasing awareness of the need to enhance the standard of healthcare services.
In addition, the rising incidence rate of traffic accidents and injuries is driving up demand in the advanced wound care market in the APAC region. New approaches for wound treatment are more effective in healing wounds in a shorter amount of time, which is beneficial to the market growth rate. It is projected that an increase in the population of elderly individuals as well as an increase in the number of diabetes patients would drive the demand in the market. For example, more than sixty percent of people in the Asia Pacific region are afflicted with diabetes.
Also, a rising focus on lowering the risk of infection in the wound is projected to be a driving force behind the expansion of the market. In addition, the use of these wound care procedures increases patient satisfaction, which is another element contributing to the expansion of the market. In addition, an increase in the number of cases of wounds that are difficult to heal is expected to contribute to the market's growing demand.
The high cost of these product offers is one of the most significant limiting factors that is preventing the widespread adoption of sophisticated wound dressings in the region. It is anticipated that the combination of this factor and the inadequate compensation supplied in the Asian nations would result in a reduction in the use of the associated items.
It is anticipated that the high cost of expenditure on wound care therapy, along with the presence of unfavourable reimbursement regulations in developing nations, will restrain the growth of the market. Therefore, the adoption of these items in the Asian market is decreasing as a result of the higher out-of-pocket expenses connected with these medicines as well as the restricted reimbursement for these essential products.
The worldwide Asia Pacific advanced wound dressing market is divided into four categories: product, application, end-user, and geography.
Foam, hydrocolloid, film, alginate, hydrogel, collagen, and other advanced dressings make up the worldwide advanced wound dressing market. In 2021, the hydrocolloid dressing segment had a considerable market share, and it is expected to increase at the quickest rate throughout the projected period. At a CAGR of 5%, it is predicted to reach a total value of USD 2,080 million by 2030. Gel-forming materials including carboxymethylcellulose (CMC) and gelatin are used in hydrocolloid dressings. These materials are occlusive, which aids in the retention of moisture. These dressings promote rapid healing and are bacterial infection resistant. As a result, both inside and externally, it helps to protect wounds.
Furthermore, throughout the projection period, rising diabetes incidence around the world are predicted to boost category growth. In 2015, about 5% of individuals in the United States were diagnosed with Type 1 diabetes, according to the CDC. Diabetic sores or diabetic ulcers affect around 15% of the diabetic population. As a result, throughout the projection period, demand for hydrocolloid wound dressing is expected to rise.
The worldwide advanced wound dressing market is segmented into chronic and acute wounds based on application. In 2021, the acute wound segment had the greatest market share. At a CAGR of 4.5%, it is predicted to reach a value of USD 6,430 million by 2030. Surgical and traumatic wounds, as well as burns, are among the acute wounds. Due to the rising number of instances of trauma in the United States, the surgical and traumatic wounds category had the biggest proportion. According to the World Health Organization (WHO), trauma accounts for around 9% of worldwide mortality in 2019.
Hospitals, specialised clinics, home healthcare, and others are among the end-users in the worldwide Asia Pacific advanced wound dressing market. The market was dominated by the hospital segment. At a CAGR of 4.5%, it is predicted to reach a value of USD 4,850 million by 2030. The key category expansion driver is the increased prevalence of diabetic foot ulcers and venous leg ulcers. Furthermore, as the number of procedures grows, the chance of surgical wounds grows, driving the sector ahead. Advanced wound dressing is frequently used to treat SSI wounds. As a result, such factors may help to improve segment growth throughout the forecasted term.
Because of the limited bed capacity in hospitals and the preference for homecare treatment, Asia is the fastest-growing market in the world. As a result, the demand for rapid wound healing is becoming increasingly important. The advanced wound care market in Asia is presently led by Japan. China and India, however, being the most populous nations in the area, contribute to the market's expanding demand. Because of its larger population, expanding diabetes population, increased patient awareness, and higher disposable budgets, the Asian market has huge development potential. The market's expansion in this region, however, has been hampered by a lack of understanding and price sensitivity.
The market in the Asia-Pacific area is more important, since trends demonstrate that consumers want more efficient treatments for their ailments. Furthermore, this technology is geared for the region's older population, who place a premium on easy access to healthcare.
During the projected period, the Japanese advanced wound care industry is expected to play a promising position in the APAC market. This region's market growth is boosted by rising discretionary spending and increased awareness of the advantage's advanced wound care dressing supplier. In addition, as injuries take longer to heal from, the population of elderly people is growing, which is fueling the region's growth. In Japan, moderate diabetes is the leading cause of foot ulcers.
The Advanced Wound Care Market in China is expected to develop at a lucrative pace due to the rising need for wound care treatment, particularly foot ulcers, among the diabetic patient population, as well as the ever-increasing occurrence rate of continual injuries and rising number of operations. In addition, one million people suffer serious injuries as a result of traffic accidents. The market's demand is soaring due to the launch of new items with cutting-edge technology and the growing demand for approvals of innovative products.
Due to the rising prevalence of diabetes and the increasing number of patients with diabetic wounds, India's advanced wound care industry is predicted to develop at the quickest rate. Diabetes affected 73 million people in 2017, and the number is expected to rise to roughly 134.4 million by 2045.
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends|